Wellcome

Theranostics Approaches to Gastric and Colon Cancer (Record no. 548773)

MARC details
000 -LEADER
fixed length control field 04411nam a22005655i 4500
001 -
control field 978-981-15-2017-4
003 -
control field DE-He213
005 -
control field 20211012172312.0
007 -
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200304s2020 si | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789811520174
-- 978-981-15-2017-4
024 7# -
-- 10.1007/978-981-15-2017-4
-- doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
-- RC261-271
072 #7 -
-- MJCL
-- bicssc
-- MED062000
-- bisacsh
-- MJCL
-- thema
082 04 -
Classification number 614.5999
-- 23
245 10 - TITLE STATEMENT
Title Theranostics Approaches to Gastric and Colon Cancer
Statement of responsibility, etc edited by Ganji Seeta Rama Raju, L.V.K.S. Bhaskar.
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2020.
300 ## - PHYSICAL DESCRIPTION
Extent XIII, 250 p. 26 illus., 17 illus. in color.
Other physical details online resource.
505 0# -
Formatted contents note Chapter 1. Therapeutic role of Phytochemicals in Colorectal cancer -- Chapter 2. Adiponectin Signaling In Colorectal Cancer -- Chapter 3. Role of Matrix Metalloproteinases in Colorectal Cancer -- Chapter 4. The Role of Hypoxia-Inducible Factor 1- Alpha in Colorectal Cancer -- Chapter 5. Mechanisms and pathways of metabolic reprogramming of colorectal cancer -- Chapter 6. Targeting metabolic reprogramming of colorectal cancer -- Chapter 7. Understanding colorectal cancer: the basics -- Chapter 8. Molecular signaling pathways involved in gastric cancer chemoresistance -- Chapter 9. Meta-analysis reveals no significant association of EPHX1 Tyr113His and His139Arg polymorphisms with the colorectal cancer risk -- Chapter 10. Meta-analysis of genetic variants in alcohol metabolizing enzymes and their association with colorectal cancer risk -- Chapter 11. Gut microbiota as signatures in non-communicable diseases and mucosal immunity -- Chapter 12. Immunotherapy for Colon Cancer: Recent Perspectives -- Chapter 13. Nanotechnology Applications in Gastric cancer. .
650 #0 -
Topical term or geographic name as entry element Cancer research.
Topical term or geographic name as entry element Gastroenterology .
Topical term or geographic name as entry element Oncology  .
Topical term or geographic name as entry element Genetics.
Topical term or geographic name as entry element Cancer Research.
Topical term or geographic name as entry element Gastroenterology.
Topical term or geographic name as entry element Oncology.
Topical term or geographic name as entry element Genetics and Genomics.
700 1# -
Personal name Raju, Ganji Seeta Rama.
Relator term editor.
Personal name Bhaskar, L.V.K.S.
Relator term editor.
710 2# -
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
856 40 -
Uniform Resource Identifier https://doi.org/10.1007/978-981-15-2017-4
245 10 - TITLE STATEMENT
-- [electronic resource] /
264 #1 -
-- Singapore :
-- Springer Singapore :
-- Imprint: Springer,
-- 2020.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
490 1# -
-- Diagnostics and Therapeutic Advances in GI Malignancies,
-- 2662-2696
520 ## -
-- This book highlights the importance of understanding gastric and colon cancer metabolism in guiding diagnosis and drug discovery. It summarizes the correlation between adiponectin and matrix metalloproteinase with colorectal cancer. The book also evaluates the divergent role of hypoxia-inducible factor 1 in colorectal cancer growth and metastasis. After discussing the role of genetic polymorphisms in alcohol metabolizing enzymes and EPHX1 with the onset of colorectal cancer, it reviews the molecular mechanisms of chemoresistance in gastric cancer and novel therapeutic strategies to reverse the chemoresistance of tumors. In addition, the book explores the theranostic role of nanoparticles and therapeutic potential of phytochemicals with regard to colorectal cancer. Given its scope, the book offers a valuable guide for oncologists, academic researchers, pharmaceuticals practitioners, and students who are involved in research and treatment of cancer.
-- https://scigraph.springernature.com/ontologies/product-market-codes/B11001
-- https://scigraph.springernature.com/ontologies/product-market-codes/H33061
-- https://scigraph.springernature.com/ontologies/product-market-codes/H33160
-- https://scigraph.springernature.com/ontologies/product-market-codes/L32000
700 1# -
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
-- edt
-- http://id.loc.gov/vocabulary/relators/edt
773 0# -
-- Springer Nature eBook
776 08 -
-- Printed edition:
-- 9789811520167
-- Printed edition:
-- 9789811520181
-- Printed edition:
-- 9789811520198
830 #0 -
-- Diagnostics and Therapeutic Advances in GI Malignancies,
-- 2662-2696
912 ## -
-- ZDB-2-SBL
-- ZDB-2-SXB
950 ## -
-- Biomedical and Life Sciences (SpringerNature-11642)
-- Biomedical and Life Sciences (R0) (SpringerNature-43708)
Holdings
Withdrawn status Lost status Damaged status Home library Current library Date acquired Total Checkouts Date last seen Koha item type
      Mysore University Main Library Mysore University Main Library 12/10/2021   12/10/2021 Ebooks

No. of hits (from 9th Mar 12) :

Powered by Koha